Wealth Enhancement Advisory Services’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-7,859
Closed -$1.12M 248
2019
Q1
$1.12M Buy
+7,859
New +$1.14M 0.06% 127
2017
Q4
Sell
-3,396
Closed -$702K 177
2017
Q3
$702K Buy
+3,396
New +$790K 0.06% 134

Other funds holding AGN

Wealth Enhancement Advisory Services's AGN Position: Q2 2019 in Review

Wealth Enhancement Advisory Services sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 7,859 shares — an estimated $1.12M sold.

Wealth Enhancement Advisory Services first reported a position in AGN in Q3 2017 and held it in 2 quarters. The position peaked at $1.12M in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Wealth Enhancement Advisory Services reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 7,859 Allergan plc shares in Q2 2019, an estimated $1.12M.
  • Wealth Enhancement Advisory Services first reported a position in Allergan plc in Q3 2017 and held it in 2 quarters.
  • Wealth Enhancement Advisory Services's Allergan plc position peaked at $1.12M in Q1 2019.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2019, filed 2 Aug 2019.